袖状胃切除术助力重度肥胖左心室辅助装置患者减重并接受心脏移植
4例(33.3%)随后接受原位心脏移植,移植时平均BMI降至32.8,66.7%患者达到目标BMI<35。袖状胃切除术在此高危人群中安全有效,可作为桥接心脏移植的减重手段。
要点
- 袖状胃切除术在LVAD患者中安全可行,术后出血和便血并发症可控。
- 66.7%患者达到BMI<35的目标,33.3%成功接受心脏移植。
- 从袖状胃切除到心脏移植平均间隔17.9个月,期间BMI平均下降至32.8。
核心结论
- 袖状胃切除术在需要LVAD的重度肥胖心衰患者中是安全有效的手术,可使多数患者BMI降至35以下并有机会接受心脏移植。
主要发现
- 心脏移植患者从LVAD置入到袖状胃切除平均年龄41.0岁至43.9岁,移植时平均45.3岁。
- 平均BMI从LVAD置入时38.8升至袖状胃切除前42.5,移植时降至32.8,末次随访31.9。
- 从袖状胃切除到心脏移植平均时间17.9个月。
- 1例术后第1天因出血重返手术室,1例术后第7天因便血再入院保守治疗。
关键数值与推荐
- 66.7%的患者达到目标BMI<35,33.3%接受心脏移植。
临床怎么用
- 对于LVAD支持且BMI>35的重度肥胖心衰患者,可考虑袖状胃切除术以降低BMI并桥接心脏移植。
- 围术期需注意抗凝管理,警惕术后出血和便血并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Patients suffering from advanced heart failure may undergo left ventricular assist device (LVAD) placement as a bridge to cardiac transplantation. However, those with a BMI above 35 kg/m2 are generally not considered eligible for transplant due to their elevated cardiac risk. We review our experience with bariatric surgery in this high-risk population to assess its safety and efficacy in reducing BMI to permit cardiac transplantation. METHODS: We retrospectively reviewed all patients on durable LVAD support who underwent sleeve gastrectomy (SG) at Mount Sinai Hospital between August 2018 and December 2022. Electronic medical records were reviewed to analyze patient demographics, surgical details, and outcomes regarding weight loss and heart transplantation. RESULTS: We identified twelve LVAD patients who underwent SG. Three were performed laparoscopically and 9 via robotic approach. Four patients (33.3%) underwent an orthotopic heart transplant (OHTx). Half of these patients were female. For patients who underwent OHTx, mean age at LVAD placement was 41.0 (R30.6-52.2), at SG was 43.9 (R32.7-55.0) and at OHTx was 45.3 years (R33.3-56.8). Mean BMI increased from 38.8 at LVAD placement to 42.5 prior to SG. Mean time from SG to OHTx was 17.9 months (R6-7-27.5) during which BMI decreased to mean 32.8 at the time of OHTx. At most recent follow-up, mean BMI was 31.9. All patients were anticoagulated prior to surgery; one required return to the operating room on post-operative day 1 after SG for bleeding and one was re-admitted on post-operative day 7 for hematochezia treated conservatively. CONCLUSION: SG is a safe and effective operation in patients with severe obesity and heart failure requiring an LVAD. 66.7% of our cohort achieved target BMI < 35 and 33.3% underwent heart transplantation. Longer term follow-up is needed to clarify full bridge-to-transplant rate and long-term survival outcomes.
引用
- Tsai C, Dolan P, Moss N, et al. Sleeve gastrectomy facilitates weight loss and permits cardiac transplantation in patients with severe obesity and a left ventricular assist device (LVAD). Surg Endosc. 2023. PMID: 37495848. doi:10.1007/s00464-023-10264-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。